PSS

Quote







Ditto!!!! Could not have said it better!
anonymous said:
I also have an extensive buy and bill resume and could not agree more. After 2 full years of selling Leqvio, and an extra year to prepare, Novartis still has no idea how other companies successfully sell buy and bill or isn’t willing to learn. We have sales training, sales leaders, reimbursement people, and most glaringly, leadership, who think we are selling a “prescription” and are desperately searching for nonexistent “script data.” We are chasing provider based metrics while being “trained” on account based selling. We are targeting offices with scant potential and still aren’t targeting offices that have been ordering Leqvio for 2 years. Moreover, we hired salespeople with experience successfully selling buy and bill products, then don’t allow them to make the decisions of where to get their business. Anyone who is successful in spite of all that will need to split their success with their entire Area too.
Click to expand...
 



Whoever owned the decision on a pop health driven launch should be fired. Whoever decided that the entresto sales force could launch this drug (instead of investing in a buy and bill specialized team) should be fired. Sales Directors, RDs, ABLs never got it and the longer the WRONG people are in place, the more damage this brand will take. Whoever decided to bring on 150 person access and reimbursement team should be fired. Whoever decided to let an exclusively Rx drug Marketing team try to launch this drug should be fired.

LEADERSHIP COMEDY OF ERRORS! #cleanhouse

Dont blame the reps for being clueless and ineffective. They had the worst leadership ever seen in the history of pharmaceutical launches.
 


















Came over from Genentech a few years ago to be on the FRM team at Novartis. I was shocked at the incompetence level of the average employee at Novartis. (Genentech is also hurting these days after Roche fully took over) NVS definitely wasn’t hiring the best and the brightest especially in the higher management ranks. Many Genentech people who came over tried to assist others who had no BnB experience but the attitude was people afraid to say they didn't understand and hid behind each others whining instead of learning. Very little mental horsepower inside the Novartis CRM team to be brutally honest.

Most pharma companies based out of Europe, especially Basel, are so left that they convinced themselves they could hire people based on sexuality, color, gender instead of competence and still win. Now these idiots are reaping what they sowed.
 



anonymous said:
Came over from Genentech a few years ago to be on the FRM team at Novartis. I was shocked at the incompetence level of the average employee at Novartis. (Genentech is also hurting these days after Roche fully took over) NVS definitely wasn’t hiring the best and the brightest especially in the higher management ranks. Many Genentech people who came over tried to assist others who had no BnB experience but the attitude was people afraid to say they didn't understand and hid behind each others whining instead of learning. Very little mental horsepower inside the Novartis CRM team to be brutally honest.

Most pharma companies based out of Europe, especially Basel, are so left that they convinced themselves they could hire people based on sexuality, color, gender instead of competence and still win. Now these idiots are reaping what they sowed.
Click to expand...
Novartis has a culture of extreme bureacracy. I was hoping that T4G would have eliminated some of it but it only made it worse as people became job protectionist.
 



anonymous said:
Came over from Genentech a few years ago to be on the FRM team at Novartis. I was shocked at the incompetence level of the average employee at Novartis. (Genentech is also hurting these days after Roche fully took over) NVS definitely wasn’t hiring the best and the brightest especially in the higher management ranks. Many Genentech people who came over tried to assist others who had no BnB experience but the attitude was people afraid to say they didn't understand and hid behind each others whining instead of learning. Very little mental horsepower inside the Novartis CRM team to be brutally honest.

Most pharma companies based out of Europe, especially Basel, are so left that they convinced themselves they could hire people based on sexuality, color, gender instead of competence and still win. Now these idiots are reaping what they sowed.
Click to expand...
Agree. I’m one of the few in the sales force who came here with BnB experience and after all this time, Novartis STILL doesn’t really understand BnB. I will say there are some of us doing fairly well, but with team goals, we aren’t really getting paid for it. And you can pretty much look at where the success is happening and find some salespeople who were trained to do BnB at another company. Novartis still thinks someone is going to “write” or “prescribe” Leqvio. We still bring in an army of people to set up “the pathway” instead of finessing the setup so offices aren’t overwhelmed with how complicated it is.
More than anything, Novartis doesn’t understand BnB takes a hunter mentality and the only way to get that out of people is to reward them well in bonus or commission.
 



anonymous said:
Agree. I’m one of the few in the sales force who came here with BnB experience and after all this time, Novartis STILL doesn’t really understand BnB. I will say there are some of us doing fairly well, but with team goals, we aren’t really getting paid for it. And you can pretty much look at where the success is happening and find some salespeople who were trained to do BnB at another company. Novartis still thinks someone is going to “write” or “prescribe” Leqvio. We still bring in an army of people to set up “the pathway” instead of finessing the setup so offices aren’t overwhelmed with how complicated it is.
More than anything, Novartis doesn’t understand BnB takes a hunter mentality and the only way to get that out of people is to reward them well in bonus or commission.
Click to expand...
Even the "reimbursement" team is clueless on BnB, they are worst-in-class.

If you are one of the many ADARs whose first role in BnB reimbursement is on the Leqvio team, you don't even know what you dont know. The Market Access team is the same when it comes to BnB - unaware of how big the gap actually is.
 



Top Bottom
Back
Quote